title: Intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy recalcitrant to conventional therapy.
abstract: Chronic idiopathic demyelinating polyneuropathy is an immunologically mediated disorder that may not respond to glucocorticoid therapy, cytotoxic or other immunosuppressive medications, or plasmapheresis. We have reported such a case in which the patient had sustained clinical improvement with the repeated administration of high doses of intravenous immunoglobulin.
authors.affiliation: Department of Pediatrics, University of South Florida, St. Petersburg.
authors.forename: K
authors.initials: K
authors.lastname: Urval
authors.forename: R P
authors.initials: RP
authors.lastname: Nelson
authors.forename: S R
authors.initials: SR
authors.lastname: Cohen
authors.forename: R A
authors.initials: RA
authors.lastname: Good
mesh_terms: D002908:Chronic Disease; D003711:Demyelinating Diseases / Q000628:therapy*; D004351:Drug Resistance; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D011241:Prednisone / Q000627:therapeutic use
chemical_list: D016756:Immunoglobulins, Intravenous; D011241:Prednisone